{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-238355","form_type":"8-K","ticker":"MD","cik":"0000893949","company_name":"Pediatrix Medical Group, Inc.","filed_at":"2021-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:04:21.162692+00:00","generated_at":"2026-06-29T21:06:39.384749+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Mednax Q2: GAAP EPS $0.36, adj EPS $0.41, revenue $473M (+14% YoY), volume strong","bullets":["Net revenue $473M vs $415.4M prior year; income from cont ops $30.5M ($0.36 diluted) vs $7.1M ($0.08).","Adjusted EPS $0.41 vs $0.26; adjusted EBITDA $65.5M vs $55.7M.","Same-unit revenue +13.4% (volume +9.5%, reimbursement +3.9%); office-based services volume +23.2%.","No CARES Act funds in Q2'21 vs $5.8M in Q2'20; gain on building sale $7.3M excluded from adj metrics.","Redeemed $750M 5.25% notes due 2023 in Jan 2021; debt now $1.0B with no revolver borrowings."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-238355","json":"https://secwatch.observer/filing/0001193125-21-238355.json","markdown":"https://secwatch.observer/filing/0001193125-21-238355.md","text":"https://secwatch.observer/filing/0001193125-21-238355.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/893949/000119312521238355/0001193125-21-238355-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/893949/000119312521238355/d212310d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T21:06:39.384749+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}